{"id":211591,"title":"Guidance Policy - Use of Positron Emitting Radiopharmaceuticals (PERs) in Basic Research Policy (POL-0053) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T22:43:08.770000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/guidance-policy-use-positron-emitting-radiopharmaceuticals-basic-research-0053.html?wbdisable=false","snippet":"Guidance Policy - Use of Positron Emitting Radiopharmaceuticals (PERs) in Basic Research Policy (POL-0053) - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs and…","rawSnapshotUrl":"/api/snapshots/raw/211591","browseUrl":"https://replay.healtharchive.ca/job-1/20250418224308/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/drugs/guidance-policy-use-positron-emitting-radiopharmaceuticals-basic-research-0053.html?wbdisable=false#ha_snapshot=211591","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}